International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
26(1), P. 57 - 57
Published: Dec. 25, 2024
As
the
organism
ages,
there
is
a
decline
in
effective
energy
supply,
and
this
retards
ability
to
elaborate
new
proteins.
The
consequences
of
are
especially
marked
gradual
brain
function.
senescence
cells
their
constituent
organelles
ultimately
cause
aging
entire
nervous
system.
What
less
immediately
obvious
that
also
accompanied
by
failure
catabolic
events
lead
removal
non-functional
ineffective
subcellular
components.
non-working
cellular
elements
within
essential
order
allow
appearance
fresh
with
full
range
capacities.
Thus,
maintenance
operative
mechanisms
for
dispersal
failed
tissue
components
important,
its
diminished
capacity
significant
contributory
factor
onset
progression
age-related
neurological
disorder.
This
report
discusses
underlying
autophagy
phagocytosis
how
these
can
be
adversely
modulated
as
proceeds.
means
which
recycling
may
reinstated
aged
considered.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(13), P. 6901 - 6901
Published: June 24, 2024
Alzheimer's
disease
(AD)
is
the
most
prevalent
neurodegenerative
disorder
and
affects
millions
of
individuals
globally.
AD
associated
with
cognitive
decline
memory
loss
that
worsens
aging.
A
statistical
report
using
U.S.
data
on
estimates
approximately
6.9
million
suffer
from
AD,
a
number
projected
to
surge
13.8
by
2060.
Thus,
there
critical
imperative
pinpoint
address
its
hallmark
tau
protein
aggregation
early
prevent
manage
debilitating
effects.
Amyloid-β
proteins
are
primarily
formation
plaques
neurofibril
tangles
in
brain.
Current
research
efforts
focus
degrading
amyloid-β
or
inhibiting
their
synthesis,
particularly
targeting
APP
processing
hyperphosphorylation,
aiming
develop
effective
clinical
interventions.
However,
navigating
this
intricate
landscape
requires
ongoing
studies
trials
treatments
truly
make
difference.
Genome-wide
association
(GWASs)
across
various
cohorts
identified
40
loci
over
300
genes
AD.
Despite
wealth
genetic
data,
much
remains
be
understood
about
functions
these
role
process,
prompting
continued
investigation.
By
delving
deeper
into
associations,
novel
targets
such
as
kinases,
proteases,
cytokines,
degradation
pathways,
offer
new
directions
for
drug
discovery
therapeutic
intervention
This
review
delves
biological
pathways
disrupted
identifies
how
variations
within
could
serve
potential
treatment
strategies.
Through
comprehensive
understanding
molecular
underpinnings
researchers
aim
pave
way
more
therapies
can
alleviate
burden
devastating
disease.
Intervention
in
chronically
activated
microglia-mediated
neuroinflammation
is
a
novel
approach
to
treat
Alzheimer's
disease
(AD).
The
low
permeability
of
the
blood‒brain
barrier
(BBB)
and
non-selective
distribution
brain
severely
restrict
AD
drugs'
disease-modifying
efficacy.
Here,
an
immunosuppressant
TREM2-lowing
antisense
oligonucleotides
(ASOs)
resveratrol
co-loaded
cationic
liposome
developed
as
immune
reprogramming
nanomodulator
modified
by
acid-cleavable
BBB-targeting
peptide
microglia-targeting
(Res@TcMNP/ASO)
for
management.
Res@TcMNP/ASO
can
enter
endothelial
cells
via
D-T7
peptides.
Then
undergoes
acid-responsive
cleavage,
facilitating
escape
Res@MNP/ASO
from
endo/lysosomes
cross
BBB.
detached
specifically
targets
M1-phenotype
microglia
exposed
MG1
peptides
prompt
simultaneous
delivery
two
drugs
into
microglia.
This
not
only
restore
function
through
ASO
but
also
mitigate
stimulation
caused
reactive
oxygen
species
(ROS)
resveratrol,
thereby
synergistically
inhibiting
chronic
activation
alleviate
AD.
Our
results
indicate
that
this
combination
treatment
achieve
significant
behavioral
cognitive
improvements
late
APP/PS1
mice.
Frontiers in Aging Neuroscience,
Journal Year:
2024,
Volume and Issue:
16
Published: April 17, 2024
This
review
provides
a
comprehensive
examination
of
the
role
clathrin-mediated
endocytosis
(CME)
in
Alzheimer's
disease
(AD)
pathogenesis,
emphasizing
its
impact
across
various
cellular
contexts
beyond
neuronal
dysfunction.
In
neurons,
dysregulated
CME
contributes
to
synaptic
dysfunction,
amyloid
beta
(Aβ)
processing,
and
Tau
pathology,
highlighting
involvement
early
AD
pathogenesis.
Furthermore,
alterations
extend
non-neuronal
cell
types,
including
astrocytes
microglia,
which
play
crucial
roles
Aβ
clearance
neuroinflammation.
Dysregulated
these
cells
underscores
broader
implications
pathophysiology.
Despite
significant
progress,
further
research
is
needed
elucidate
precise
mechanisms
underlying
dysregulation
therapeutic
implications.
Overall,
understanding
complex
interplay
between
diverse
types
holds
promise
for
identifying
novel
targets
interventions.
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 24, 2025
Abstract
Alzheimer's
disease
(AD)
is
less
prevalent
in
men
than
women,
although
mechanisms
remain
unclear.
Microglia
degrade
aggregated
amyloid
β
(Aβ)
through
the
lysosomal
system,
including
autophagy.
G
protein‐coupled
receptor
family
C
group
6
member
A
(GPRC6A),
predominantly
expressed
mouse
microglial
MG6
cells,
a
primary
mediator
of
testosterone
signaling.
This
study
examines
testosterone's
role
modulating
Aβ‐induced
autophagy
microglia.
Testosterone
promotes
leading
to
Aβ
clearance
cells
by
suppressing
extracellular
signal‐regulated
kinase
(ERK)
phosphorylation
and
subsequently
inhibiting
mammalian
target
rapamycin
(mTOR)
activation,
which
abrogated
shRNA
knockdown
GPRC6A.
In
vivo
experiments
with
male
5xFAD
AD
model
mice,
activity
associated
microglia
reduced
orchiectomy,
but
restored
supplementation.
ERK
brains
mice
upregulated
orchiectomy.
Therefore,
involved
autophagy‐mediated
accumulation
human
brain
samples
from
patients
significantly
lower
pronounced
colocalization
p62
aggregates,
suggesting
enhanced
autophagic
men.
conclusion,
enhances
microglia,
possibly
contributing
susceptibility
Journal of Alzheimer s Disease,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 23, 2025
Background
Alzheimer's
disease
(AD)
is
the
most
prevalent
neurodegenerative
disorder
characterized
by
cognitive
deficit
and
pathological
accumulation
of
amyloid-β
(Aβ)
tau
proteins.
The
rodent
models
have
contributed
greatly
to
unravel
AD
pathogenesis,
but
these
been
shown
a
modest
clinical
translational
effectiveness.
Objective
Therefore,
developing
mass-producible
primate
promising
for
more
effective
drug
development.
Methods
Here,
we
constructed
monkey
simultaneously
infusing
AAV-Tau
Aβ
into
different
brain
regions.
Results
induced
monkeys
showed
durable
impairment
lasting
at
least
10
months
after
modeling.
Simultaneously,
increased
levels
total
hyperphosphorylated
(pTau)
several
AD-associated
sites,
neurofilament
light
chains
(NfL)
with
altered
level
were
detected
time
points
in
cerebrospinal
fluid
and/or
plasma
using
MSD
kits.
proteins
was
also
positron
emission
tomography/magnetic
resonance
imaging
immunohistochemical
staining.
model
had
significant
glial
activation;
an
indicator
inflammation
commonly
seen
brains
patients.
Conclusions
Together,
this
study
provides
showing
AD-like
hallmark
pathologies
(Aβ,
tau,
NfL,
i.e.,
ATN)
deficits.
As
are
genetically
metabolically
closest
humans,
will
offer
discovery
development
AD.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(24), P. 17377 - 17377
Published: Dec. 12, 2023
Research
into
Alzheimer's
Disease
(AD)
describes
a
link
between
AD
and
the
resident
immune
cells
of
brain,
microglia.
Further,
this
suspected
is
thought
to
have
underlying
sex
effects,
although
mechanisms
these
effects
are
only
just
beginning
be
understood.
Many
insights
result
policies
put
in
place
by
funding
agencies
such
as
National
Institutes
Health
(NIH)
consider
biological
variable
(SABV)
move
towards
precision
medicine
due
continued
lackluster
therapeutic
options.
The
purpose
review
provide
an
updated
assessment
current
research
that
summarizes
differences
pertaining
microglia
their
varied
responses
AD.